Sam Penza

1.4k total citations
63 papers, 806 citations indexed

About

Sam Penza is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sam Penza has authored 63 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 25 papers in Oncology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Sam Penza's work include Hematopoietic Stem Cell Transplantation (28 papers), Lymphoma Diagnosis and Treatment (16 papers) and Acute Myeloid Leukemia Research (11 papers). Sam Penza is often cited by papers focused on Hematopoietic Stem Cell Transplantation (28 papers), Lymphoma Diagnosis and Treatment (16 papers) and Acute Myeloid Leukemia Research (11 papers). Sam Penza collaborates with scholars based in United States and Australia. Sam Penza's co-authors include Patrick Elder, Steven M. Devine, Don M. Benson, William Blum, Leslie A. Andritsos, Craig C. Hofmeister, Samantha Jaglowski, Rebecca B. Klisovic, Thomas S. Lin and Belinda R. Avalos and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Sam Penza

59 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sam Penza United States	17	467	321	188	134	118	63	806
Xiaochun Zhu United States	12	509 1.1×	250 0.8×	371 2.0×	158 1.2×	147 1.2×	35	969
S Andresen United States	19	620 1.3×	442 1.4×	201 1.1×	99 0.7×	128 1.1×	35	998
Ivetta Danylesko Israel	17	495 1.1×	299 0.9×	124 0.7×	173 1.3×	73 0.6×	67	842
Willis H. Navarro United States	15	350 0.7×	334 1.0×	87 0.5×	128 1.0×	126 1.1×	54	728
Zaid Al‐Kadhimi United States	18	425 0.9×	540 1.7×	337 1.8×	98 0.7×	82 0.7×	84	1.0k
Taru Kuittinen Finland	18	468 1.0×	390 1.2×	122 0.6×	86 0.6×	157 1.3×	44	817
Federica Galaverna Italy	15	581 1.2×	333 1.0×	267 1.4×	151 1.1×	61 0.5×	48	867
Abraham S. Kanate United States	17	371 0.8×	376 1.2×	126 0.7×	103 0.8×	197 1.7×	61	815
Philip A. Stevenson United States	14	298 0.6×	199 0.6×	353 1.9×	78 0.6×	102 0.9×	45	733
Arjun Law Canada	17	619 1.3×	391 1.2×	275 1.5×	201 1.5×	58 0.5×	142	1.0k

Countries citing papers authored by Sam Penza

Since Specialization

Citations

This map shows the geographic impact of Sam Penza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Penza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Penza more than expected).

Fields of papers citing papers by Sam Penza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Penza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Penza. The network helps show where Sam Penza may publish in the future.

Co-authorship network of co-authors of Sam Penza

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Penza. A scholar is included among the top collaborators of Sam Penza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Penza. Sam Penza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wall, Sarah, Sam Penza, Kevin K.W. Ho, et al.. (2025). Axatilimab Combination Therapies with Ruxolitinib and/or Belumosudil Induces Clinical Responses in Patients with Severe, Treatment-Refractory Chronic Gvhd. Transplantation and Cellular Therapy. 31(2). S82–S83.

Jiang, Justin, Audrey M. Sigmund, Qiuhong Zhao, et al.. (2024). Impact of chronic graft- versus -host disease on non-relapse mortality and survival. Leukemia & lymphoma. 65(11). 1698–1705. 1 indexed citations

Murakami, Mark A., Laura Connelly‐Smith, Thomas R. Spitzer, et al.. (2024). Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance. Transplantation and Cellular Therapy. 30(7). 663–680. 3 indexed citations

Faisal, Muhammad Salman, Walter Hanel, Timothy Voorhees, et al.. (2023). Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents. Cancer Medicine. 12(7). 8228–8237. 2 indexed citations

Jiang, Justin, Audrey M. Sigmund, Qiuhong Zhao, et al.. (2022). Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience. Cancers. 14(22). 5587–5587. 3 indexed citations

Sigmund, Audrey M., Nathan Denlinger, Patrick Elder, et al.. (2021). Outcomes of Large B-Cell Lymphoma Patients By Post CAR-T Salvage Regimen at a Single Institution. Blood. 138(Supplement 1). 3851–3851. 2 indexed citations

Wall, Sarah, Ying Huang, Carolyn J. Presley, et al.. (2021). Increasing Number of Geriatric Assessment-Identified Deficits Associated with Non-Receipt of Transplant Among Older Adults. Transplantation and Cellular Therapy. 27(3). S437–S438. 1 indexed citations

Zhao, Qiuhong, Patrick Elder, Jonathan E. Brammer, et al.. (2020). Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS. Leukemia & lymphoma. 62(4). 944–951. 5 indexed citations

Maakaron, Joseph, Zeinab El Boghdadly, Ying Huang, et al.. (2020). Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look. Biology of Blood and Marrow Transplantation. 26(8). e198–e201. 13 indexed citations

10.

Vasu, Sumithira, Susan Geyer, Jeffery J. Auletta, et al.. (2015). Granulocyte Colony-Stimulating Factor–Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 22(4). 658–668. 16 indexed citations

11.

Hofmeister, Craig C., Nita Williams, Susan M. Geyer, et al.. (2014). A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphoma. Leukemia & lymphoma. 56(4). 1043–1049. 8 indexed citations

12.

McBride, Ali, Brooke Crawford, Craig C. Hofmeister, et al.. (2014). Aprepitant for the control of delayed nausea and vomiting associated with the use of high-dose melphalan for autologous peripheral blood stem cell transplants in patients with multiple myeloma: a phase II study. Supportive Care in Cancer. 22(11). 2911–2916. 12 indexed citations

13.

Haverkos, Bradley M., Ali McBride, Lynn O’Donnell, et al.. (2014). An effective mobilization strategy for lymphoma patients after failed upfront mobilization with plerixafor. Bone Marrow Transplantation. 49(8). 1052–1055. 6 indexed citations

14.

Cohen, Jonathon B., Nathan C. Hall, Jeff Jones, et al.. (2013). Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphoma. Bone Marrow Transplantation. 48(9). 1212–1217. 21 indexed citations

15.

Jaglowski, Samantha, Craig C. Hofmeister, Patrick Elder, et al.. (2012). The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma. Blood. 120(21). 4286–4286. 1 indexed citations

16.

Cohen, Jonathon B., Amy S. Ruppert, Nyla A. Heerema, et al.. (2012). Complex Karyotype (CK) Is Associated with a Shortened Progression-Free Survival (PFS) in Patients (pts) with Newly Diagnosed Mantle Cell Lymphoma (MCL).. Blood. 120(21). 2691–2691. 2 indexed citations

17.

Dunavin, Neil, Lai Wei, Patrick Elder, et al.. (2012). Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma. Leukemia & lymphoma. 54(8). 1658–1664. 52 indexed citations

18.

Hamadani, Mehdi, Michael Craig, Jame Abraham, et al.. (2011). Higher Busulfan Dose Intensity Does Not Improve Outcomes of Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (AHCT) Following Fludarabine/Busulfan/Atg (FBA)-Based Reduced Toxicity Conditioning (RTC). Biology of Blood and Marrow Transplantation. 17(2). S306–S306. 2 indexed citations

19.

Griffith, Niesha, et al.. (2008). The Impact of a Long-Acting Erythropoiesis Stimulating Protein on Patient Throughput in a Hospital-Based Ambulatory Oncology Clinic. Hospital Pharmacy. 43(5). 388–395. 3 indexed citations

20.

Farag, Sherif S., Patrick Elder, Guido Marcucci, et al.. (2003). Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged ≥50 years compared to younger adults with low-risk disease. Bone Marrow Transplantation. 31(2). 87–93. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact